NCT05344729 - Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2021

Conditions

Recurrent/Metastatic Breast Cancer

Interventions

DRUG

TQB3616 Capsule

It inhibits the proliferation of tumor cells by reducing the level of retinoblastoma protein (Rb) phosphorylation in cancer cells and blocking the progression of cells from G1 to S phase.

Trial Locations (1)

130021

Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun